Your session is about to expire
← Back to Search
Behavioural Intervention
ABM-01 for Social Anxiety Disorder
N/A
Waitlist Available
Led By Tracy A Dennis-Tiwary, PhD
Research Sponsored by Hunter College of City University of New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up bi-weekly time point and at the 6 and 12 month follow-ups
Summary
This trial tests a mobile app called ABM-01 to help adults aged 22-65 with Social Anxiety Disorder. Participants use the app regularly for a period to manage and reduce their social anxiety symptoms.
Eligible Conditions
- Social Anxiety Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ bi-weekly time point and at the 6 and 12 month follow-ups
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~bi-weekly time point and at the 6 and 12 month follow-ups
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Anxiety
Depression, Anxiety, and Stress Scale (DASS-21)
Generalized Anxiety Disorder - 7 (GAD-7)
+4 moreOther study objectives
Anxiety Sensitivity Index (ASI-3)
Beck Depression Inventory II (BDI-II)
Patient Health Questionnaire (PHQ-2)
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Experimental groupExperimental Treatment1 Intervention
Participants receive active ABM-01 for the study
Group II: Placebo ControlPlacebo Group1 Intervention
Participants receive a digital control for the study
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ABM-01
2022
N/A
~150
Find a Location
Who is running the clinical trial?
Wise Therapeutics Inc.UNKNOWN
Hunter College of City University of New YorkLead Sponsor
40 Previous Clinical Trials
8,764 Total Patients Enrolled
Arcade Therapeutics Inc.UNKNOWN
Share this study with friends
Copy Link
Messenger